SURVEYS AND STUDIES Clause Samples

The "Surveys and Studies" clause establishes the requirements and procedures for conducting surveys, studies, or assessments related to the subject matter of the agreement. Typically, this clause outlines who is responsible for commissioning or performing such surveys, the standards or methodologies to be followed, and how the results will be shared or used. For example, in a real estate contract, it may require the seller to provide a recent land survey or allow the buyer to conduct environmental studies. The core function of this clause is to ensure that all parties have access to accurate and reliable information about the property or project, thereby reducing uncertainty and facilitating informed decision-making.
SURVEYS AND STUDIES. As part of the work of the Bioethics Unit, several surveys and studies are regularly conducted.
View SourceView Similar (2)
SURVEYS AND STUDIES. A. Geotechnical Engineering Study 1. Geotechnical Engineering Study - The broad objectives the Geotechnical Engineering Study will be to determine soil conditions at the site and to develop information concerning foundation design and construction recommendations for a pre-engineered pedestrian bridge. In addition, it will provide pertinent design and construction recommendations for the proposed trail elements to be constructed along the alignment, which may include retaining walls, concrete boardwalk and trails.
View SourceView Similar (2)
SURVEYS AND STUDIES. A. During the Inspection Period Purchaser shall be permitted to enter the Property and to inspect and evaluate the Property, to conduct studies thereon, and to interview Tenants. If Purchaser determines for an reason that the Property is not suitable for Purchaser’s purposes. Purchaser may terminate this Contract upon written notice to Seller and to Escrow Agent prior to the end of the Inspection Period whereupon the ▇▇▇▇▇▇▇ Money shall be refunded to Purchaser. B. Purchaser may extend the Inspection Period for up to two (2) additional consecutive ninety (90) day periods by giving notice of such extension(s) to Seller and paying an Extension Deposit to Escrow Agent Rum to the expiration of the Inspection Period (including previous extensions). All ▇▇▇▇▇▇▇ Money shall be deemed to be "at risk" and non-refundable but for Seller's default when the first Extension Deposit has been paid. C. If Purchaser desires to continue this Contract beyond the initial two hundred seventy (270) day Inspection Period it shall give written notice or same to Seller within the next business day following the end of the initial two hundred seventy (270) day Inspection Period whereupon the ▇▇▇▇▇▇▇ Money shall be deemed “at risk” and non-refundable but for Seller's default. During the Inspection Period Seller shall promptly provide Purchaser with information and documentation (to the extent same is reasonably available) requested try Purchaser to facilitate its evaluation of the Property. D. Purchaser shall hold Seller harmless from any damage caused by Purchaser, its agents or contractors, in the course of conducting such surveys and/or studies. The indemnities herein shall expressly survey the Closing or the termination of this Contract and shall be in addition to any liquidated damage provisions contained in this Contract. E. Prior to Closing Purchaser shall cause the Property to be surveyed by a registered land surveyor reasonably satisfactory to Seller. The surveyor shall certify the land area to the nearest thousandth of an acre and the Purchase Price shall be calculated based thereon.
View Source
SURVEYS AND STUDIES. Seller shall promptly provide Purchaser with information and documentation (to the extent same is reasonably available) requested by Purchaser to facilitate its evaluation of the Property. During the Inspection Period Purchaser shall be permitted to enter the Property and to inspect and evaluate the Property, to conduct studies thereon, and to interview tenants, if any. If Purchaser determines for any reason that the Property is not suitable for Purchaser's purposes, Purchaser may terminate this Contract by giving written notice of same to Seller prior to 5:00 p.m. on the last day of the Inspection Period. Upon termination of this Contract pursuant hereto, Escrow Agent shall refund the ▇▇▇▇▇▇▇ Money to Purchaser. To the extent permitted by law, Purchaser shall hold Seller harmless from any damage caused by Purchaser, its agents or contractors, in the course of conducting such surveys and/or studies. The indemnities herein shall expressly survive the Closing or the termination of this Contract and shall be in addition to any liquidated damage provisions contained in this Contract.
View Source

Related to SURVEYS AND STUDIES

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

  • Environmental Studies Promptly conduct and complete, at Borrower’s expense, all such investigations, studies, samplings and testings as may be requested by Lender or any governmental authority relative to any substance, or any waste or by-product of any substance defined as toxic or a hazardous substance under applicable federal, state, or local law, rule, regulation, order or directive, at or affecting any property or any facility owned, leased or used by Borrower.

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Trials The Ship shall run the following test and trials: (1) Harbour Acceptance Tests, including setting to work of the various equipment;

  • Surveys Each Borrower shall submit the Ship owned by it regularly to all periodical or other surveys which may be required for classification purposes and, if so required by the Security Trustee provide the Security Trustee, with copies of all survey reports.